drugset / Trial / NCT00003115

Epidural Hydromorphone Compared With Hydromorphone Infusion in Treating Patients With Prostate Cancer Undergoing Radical Prostatectomy

NCT00003115

Phase 3 Completed 40 enrolled Roswell Park Cancer Institute
Supportive care

Summary

RATIONALE: Giving hydromorphone in different ways may relieve the pain associated with cancer surgery. PURPOSE: Randomized double-blinded phase III trial to compare the effectiveness of epidural hydromorphone with hydromorphone infusion in patients with prostate cancer undergoing radical prostatectomy.

Timeline

Start
1996-06
Primary completion
2003-01
Completion
2004-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Hydromorphone Other / unclassified Other

Indications